Oklahoma recalls
3,505 federal recalls affecting Oklahoma in the last 12 months - 143 Oklahoma-specific plus 3,362 nationwide. Sourced from CPSC, FDA, USDA, and NHTSA.
- 2026-02-18FDA-DeviceMedlineClass INationwideStop using Medline ReNewal Webster CS Catheters
Medline Industries is recalling certain reprocessed Webster CS Catheters because they may contain small particles of leftover material from cleaning. If used, these particles could trigger inflammation, infection, blood clots, or serious complications like stroke or lung clots.
- 2026-02-18FDA-DevicePhilipsClass IINationwideCheck your Philips Spectral CT 7500 fasteners
Philips has recalled three Spectral CT 7500 CT scanner systems because fasteners that secure the rotor inside the gantry may not have been tightened to the correct specification. If multiple fasteners are loose, rotor parts could become unsecured or displaced during operation. No parts have been expelled or injuries reported so far.
- 2026-02-18FDA-DevicePhilipsClass IINationwideContact Philips about your Spectral CT system
Philips has recalled certain Spectral CT imaging systems because fasteners that hold the rotor in place inside the gantry may not be properly tightened. If multiple fasteners are loose, rotor parts could potentially become displaced or expelled during operation. No injuries or equipment failures have been reported so far.
- 2026-02-18FDA-DevicePhilipsClass IINationwideContact Philips about your IQon Spectral CT
Philips has identified that fasteners holding the rotor in place inside certain IQon Spectral CT scanners may not be properly tightened. While no equipment failures or injuries have been reported, loose fasteners could theoretically cause rotor parts to become unsecured during operation.
- 2026-02-18FDA-DevicePhilipsClass IINationwideContact Philips about your Brilliance iCT scanner
Philips has recalled certain Brilliance iCT CT scanners because fasteners that secure the rotor inside the gantry may not be tightened to the correct specification. If multiple fasteners are loose, rotor parts could potentially become displaced or expelled during scanning. No injuries or incidents have been reported.
- 2026-02-18FDA-DeviceHologicClass IINationwideStop using Hologic Brevera biopsy needles
Hologic's Brevera Breast Biopsy System disposable 9 gauge needles may contain tiny particles that could be deposited into breast tissue during a biopsy procedure. This affects approximately 681,870 units distributed nationwide. No injuries have been reported so far.
- 2026-02-18FDA-DeviceMedlineClass IINationwideStop using Medline Intubation Tray SKU DYNJAA245B
Medline Industries intubation kits (SKU DYNJAA245B, lots 25IBC172 and 25HBJ413) may contain an 8 Fr suction catheter instead of the correct 14 Fr size. The smaller catheter can block the airway during intubation, potentially causing severe breathing problems or failure that requires emergency intervention.
- 2026-02-18FDA-DeviceMedlineClass IINationwideStop using Medline suction catheter kit DYND40972
Some Medline 14 Fr Suction Catheter Kits (SKU DYND40972) may contain a smaller 8 Fr catheter instead of the correct 14 Fr size. Using the wrong size catheter can partially or completely block the airway, leading to low oxygen levels and breathing failure that may require emergency treatment.
- 2026-02-18FDA-FoodMcCainClass IIStop using McCain Foods Sonic Tots
McCain Foods USA Inc. is recalling Sonic Tots frozen potato product (item SON00543) because some packages may contain small hard plastic fragments. The affected product was manufactured on 10/19/2025 and distributed across multiple states. No injuries have been reported.
- 2026-02-18FDA-FoodMcCainClass IIDon't serve Ore-Ida Tater Tots item OIF00215A
McCain Foods USA Inc. is recalling specific batches of Ore-Ida Tater Tots shaped potatoes distributed to foodservice accounts (restaurants, schools, cafeterias) because they may contain small hard plastic fragments. This product was not sold in grocery stores. No injuries have been reported.
- 2026-02-18FDA-DrugMcKessonClass INationwideCheck your UDENYCA injection lot and serial number
McKesson's UDENYCA (pegfilgrastim-cbqv) injection was stored at room temperature instead of in the refrigerator, which may have reduced its effectiveness. This affected 116 cartons from Lot 2199821 with specific serial numbers. The FDA classified this as a Class I recall.
- 2026-02-18FDA-DrugMeitheal PharmaceuticalsClass IINationwideStop using Meitheal Cetrorelix Acetate injection kits
Meitheal Pharmaceuticals is recalling Cetrorelix Acetate 0.25 mg injection kits because some contain missing or duplicated needles in the delivery system. This affects lot Q4E0112A with an expiration date of April 30, 2027. The defect could prevent proper injection or cause unsafe handling.
- 2026-02-18FDA-DrugAmerisourceClass IINationwideCheck your oxycodone tablets for loose packaging
American Health Packaging is recalling certain oxycodone hydrochloride 5 mg tablets because the blister card seals are defective or missing. This allows tablets to fall out of their compartments. The recall affects 31,676 packages distributed nationwide with specific lot numbers and expiration dates.
- 2026-02-18FDA-DrugFresenius KabiClass IINationwideStop using recalled Fresenius Kabi vancomycin injection
Fresenius Kabi Compounding has recalled vancomycin HCl 2-gram doses mixed in sodium chloride solution due to concerns that sterility cannot be assured. The affected lots were distributed nationwide. This is a serious issue because non-sterile injectables can cause life-threatening infections.
- 2026-02-18FDA-DrugFresenius KabiClass IINationwideStop using Fresenius Kabi vancomycin HCl IV bags
Fresenius Kabi Compounding issued a recall of vancomycin HCl 1.5 grams in 500 mL sodium chloride solution due to lack of assured sterility. The affected lot (C274-000049628, expiring May 3, 2026) was distributed nationwide to healthcare facilities. No injuries have been reported.
- 2026-02-18FDA-DrugFresenius KabiClass IINationwideDo not use Fresenius Kabi thiamine HCl injection
Fresenius Kabi Compounding has recalled multiple lots of thiamine HCl 500 mg injection because the manufacturer cannot confirm the product is sterile. This injectable medication was distributed nationwide. The recall affects 10,548 bags with expiration dates between February and May 2026.
- 2026-02-18FDA-DrugFresenius KabiClass IINationwideDo not use Fresenius Kabi ketamine HCl injection
Fresenius Kabi Compounding has recalled five specific lots of ketamine HCl injection (10 mg per mL) distributed nationwide because the manufacturer cannot confirm the product remains sterile. The affected lots were produced between February and April 2026.
- 2026-02-18FDA-DrugFresenius KabiClass IINationwideDo not use Fresenius Kabi acyclovir sodium IV bags
Fresenius Kabi Compounding has recalled acyclovir sodium 200 mg IV injection bags because the manufacturer cannot guarantee the product is sterile. The affected bags were produced by Fagron Sterile Services and have lot number C274-000049124 with an expiration date of February 28, 2026. No infections or injuries have been reported so far.
- 2026-02-18FDA-DrugAsteria HealthClass IINationwideStop using Asteria Health testosterone pellets
Asteria Health is recalling specific lots of testosterone 100mg/anastrozole 4mg sterile pellets due to potential metal particulate matter in the product. The contamination was discovered during quality testing. No injuries have been reported.
- 2026-02-18FDA-DrugAsteria HealthClass IINationwideStop using Asteria Health testosterone pellets
Asteria Health has recalled a specific lot of testosterone and triamcinolone acetonide pellets because they may contain metal particulate matter. This contamination was discovered during manufacturing. The affected lot is 256000103, which expires July 28, 2026.
- 2026-02-18FDA-DrugAsteria HealthClass IINationwideStop using Asteria Health hormone pellets
Asteria Health is recalling a hormone medication pellet containing testosterone and triamcinolone due to the potential presence of metal particulate matter in the product. The recall affects lot 256000105 with an expiration date of September 19, 2026, distributed nationwide. No injuries have been reported.
- 2026-02-18FDA-DrugAsteria HealthClass IINationwideStop using Asteria Health hormone pellets
Asteria Health is recalling a testosterone and triamcinolone acetonide combination pellet due to the potential presence of metal particulate matter in the product. The recall affects lot #256000104 with an expiration date of 07/30/2026, distributed nationwide. No injuries have been reported.
- 2026-02-18FDA-DrugAsteria HealthClass IINationwideStop using Asteria Health testosterone pellets
Asteria Health is recalling specific lots of testosterone 75mg/anastrozole 4mg sterile pellets due to potential metal particulate matter found in the product. The affected lots were distributed nationwide. No injuries have been reported.
- 2026-02-18FDA-DrugAsteria HealthClass IINationwideStop using Asteria Health testosterone pellets
Asteria Health is recalling one lot of testosterone 100mg/anastrozole 4mg pellets because they may contain metal particles. The affected lot (254000104, expiring 05/27/2026) was distributed nationwide. No injuries have been reported.
- 2026-02-18FDA-DrugAsteria HealthClass IINationwideStop using Asteria Health testosterone pellets
Asteria Health testosterone pellets (303 mg) may contain metal particulate matter that could contaminate the product. The recall affects 1,015 pellets from lot #251000124 with an expiration date of 06/02/2026 distributed nationwide. No injuries have been reported.
- 2026-02-18FDA-DrugAsteria HealthClass IINationwideStop using Asteria Health testosterone pellets
Asteria Health testosterone pellets (200 mg) may contain metal particulate matter due to a manufacturing issue. The FDA has classified this as a Class II recall affecting multiple lot numbers distributed nationwide. No injuries have been reported to date.
- 2026-02-18FDA-DrugAsteria HealthClass IINationwideStop using Asteria Health testosterone pellets
Asteria Health is recalling certain testosterone pellet injections because they may contain metal particulate matter. The contamination was identified in seven specific manufacturing lots with expiration dates between June 2026 and September 2026. No injuries have been reported so far.
- 2026-02-18FDA-DrugAsteria HealthClass IINationwideStop using Asteria Health testosterone pellets
Asteria Health is recalling testosterone pellets (87.5 mg) because they may contain metal particles. The recall affects three specific lots distributed nationwide. No injuries have been reported so far.
- 2026-02-18FDA-DrugAsteria HealthClass IINationwideStop using Asteria Health testosterone pellets
Asteria Health testosterone pellets (62.5 mg) may contain metal particulate matter. The affected lot (251000125, expiring 06/02/2026) was distributed nationwide. About 1,758 pellets are involved in this recall.
- 2026-02-18FDA-DrugAsteria HealthClass IINationwideStop using Asteria Health testosterone pellets
Asteria Health testosterone pellets may contain metal particulate matter as a result of a manufacturing issue. The recall affects specific lot numbers distributed nationwide. No injuries have been reported to date.
Get notified about new Oklahoma recalls
Free weekly digest. Add Oklahoma to your profile to filter alerts to your state.